Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
about
Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Clarithromycin extended-release in community-acquired respiratory tract infections.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia.Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.
P2860
Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cost-effective approaches to t ...... onia in the era of resistance.
@ast
Cost-effective approaches to t ...... onia in the era of resistance.
@en
Cost-effective approaches to t ...... onia in the era of resistance.
@nl
type
label
Cost-effective approaches to t ...... onia in the era of resistance.
@ast
Cost-effective approaches to t ...... onia in the era of resistance.
@en
Cost-effective approaches to t ...... onia in the era of resistance.
@nl
prefLabel
Cost-effective approaches to t ...... onia in the era of resistance.
@ast
Cost-effective approaches to t ...... onia in the era of resistance.
@en
Cost-effective approaches to t ...... onia in the era of resistance.
@nl
P2093
P1433
P1476
Cost-effective approaches to t ...... onia in the era of resistance.
@en
P2093
Blair Capitano
David P Nicolau
Joseph L Kuti
P304
P356
10.2165/00019053-200220080-00002
P577
2002-01-01T00:00:00Z
P6179
1043682039